著者
Keishiro SHIMURA Hitoshi ITO Hiroshige HIBASAMI
出版者
(社)日本薬理学会
雑誌
The Japanese Journal of Pharmacology (ISSN:00215198)
巻号頁・発行日
vol.33, no.2, pp.403-408, 1983 (Released:2006-11-07)
参考文献数
25
被引用文献数
26 24

On crossed immunoelectrophoresis, human serum C3 (the third component of complement) converted by antitumor polysaccharides (ATSO [antitumor polysaccharide oral], AB-P [Agaricaus blazei/polysaccharide], GU-P [Grifora umbellata polysaccharide], PS-K [polysaccharide Kureha] and zymosan) moved faster than native C3, appearing as the 3rd peak. The ratio of height of the 3rd peak to the α2-macroglobulin (α2-M) peak was linearly proportional to the dose of ATSO. At the dose of 500 μg/ml antitumor polysaccharides, the ratios were higher than 0.76, and the ratios for the serum treated with polysaccharide of no antitumor activity (dextran and gum arabic) were less than about 0.52. This ratio readily determined in vivo can be used as a measure for the antitumor activity of polysaccharides.